熱門資訊> 正文

火箭制药宣布首席财务官辞职

2025-08-26 22:03

Rocket Pharmaceuticals (NASDAQ:RCKT) said that its chief financial officer, Aaron Ondrey, has announced his resignation from the company, which will be effective September 5.
The company said that on August 25, Martin Wilson, its general counsel and chief corporate officer, was appointed as the interim principal financial officer, effective September 8.
RCKT stock is down 2.6% in morning trade.

More on Rocket Pharmaceuticals

Rocket Pharmaceuticals: Good News As Clinical Hold Lifted - But Challenges Remain
Rocket Pharmaceuticals: Reeling From Dreaded Acronyms CRL And SAE
Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026
Rocket Pharma rises as FDA lifts clinical hold on gene therapy trial
Rocket Pharmaceuticals cuts headcount, realigns pipeline

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。